Thomas Braxton King - Net Worth and Insider Trading

Thomas Braxton King Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Thomas Braxton King owns 4 companies in total, including Satsuma Pharmaceuticals Inc (STSA) , VIVUS Inc (VVUSQ) , and Alexza Pharmaceuticals Inc (ALXA) among others .

Click here to see the complete history of Thomas Braxton King’s form 4 insider trades.

Insider Ownership Summary of Thomas Braxton King

Ticker	Comapny	Transaction Date	Type of Owner
STSA	Satsuma Pharmaceuticals Inc	2019-09-12	director
VVUSQ	VIVUS Inc	2020-02-20	director
ALXA	Alexza Pharmaceuticals Inc	2016-06-21	director & President & CEO
		2023-03-29	director

Thomas Braxton King Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Thomas Braxton King Ownership Network

Ownership Network List of Thomas Braxton King

No Data

Ownership Network Relation of Thomas Braxton King

Thomas Braxton King Owned Company Details

What does Satsuma Pharmaceuticals Inc do?

Who are the key executives at Satsuma Pharmaceuticals Inc?

Thomas Braxton King is the director of Satsuma Pharmaceuticals Inc. Other key executives at Satsuma Pharmaceuticals Inc include 10 percent owner Shin Nippon Biomedical Laboratories, Ltd. , director & 10 percent owner Ken Takanashi , and 10 percent owner Braden Michael Leonard .

Satsuma Pharmaceuticals Inc (STSA) Insider Trades Summary

Over the past 18 months, Thomas Braxton King made no insider transaction in Satsuma Pharmaceuticals Inc (STSA). Other recent insider transactions involving Satsuma Pharmaceuticals Inc (STSA) include a net purchase of 30,477,313 shares made by Shin Nippon Biomedical Laboratories, Ltd. , and a net purchase of 22,053,581 shares made by Ken Takanashi .

In summary, during the past 3 months, insiders sold 0 shares of Satsuma Pharmaceuticals Inc (STSA) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Satsuma Pharmaceuticals Inc (STSA) were sold and 52,530,894 shares were bought by its insiders, resulting in a net purchase of 52,530,894 shares.

Satsuma Pharmaceuticals Inc (STSA)'s detailed insider trading history can be found in Insider Trading Tracker table.

Satsuma Pharmaceuticals Inc Insider Transactions

No Available Data

What does VIVUS Inc do?

Who are the key executives at VIVUS Inc?

Thomas Braxton King is the director of VIVUS Inc. Other key executives at VIVUS Inc include director & Chief Executive Officer John P. Amos , Chief Medical Officer Santosh T Varghese , and Chief Financial Officer & CAO Mark K Oki .

VIVUS Inc (VVUSQ) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of VIVUS Inc (VVUSQ) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of VIVUS Inc (VVUSQ) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

VIVUS Inc (VVUSQ)'s detailed insider trading history can be found in Insider Trading Tracker table.

VIVUS Inc Insider Transactions

No Available Data

What does Alexza Pharmaceuticals Inc do?

Who are the key executives at Alexza Pharmaceuticals Inc?

Thomas Braxton King is the director & President & CEO of Alexza Pharmaceuticals Inc. Other key executives at Alexza Pharmaceuticals Inc include Former SVP & CFO & Secretary Mark K Oki , EVP & Operations & COO Robert A Lippe , and director & Former EVP & R&D and CSO James V Cassella .

Alexza Pharmaceuticals Inc (ALXA) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Alexza Pharmaceuticals Inc (ALXA) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Alexza Pharmaceuticals Inc (ALXA) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Alexza Pharmaceuticals Inc (ALXA)'s detailed insider trading history can be found in Insider Trading Tracker table.

Alexza Pharmaceuticals Inc Insider Transactions

No Available Data

What does Achieve Life Sciences Inc do?

Who are the key executives at Achieve Life Sciences Inc?

Thomas Braxton King is the director of Achieve Life Sciences Inc. Other key executives at Achieve Life Sciences Inc include CFO and PFO John Bencich , director & President & CEO Richard Alistair Stewart , and 10 percent owner Dialectic Life Sciences Spv Llc .

Achieve Life Sciences Inc (ACHV) Insider Trades Summary

Over the past 18 months, Thomas Braxton King made no insider transaction in Achieve Life Sciences Inc (ACHV). Other recent insider transactions involving Achieve Life Sciences Inc (ACHV) include a net purchase of 15,000 shares made by John Bencich , and a net purchase of 10,000 shares made by Richard Alistair Stewart .

In summary, during the past 3 months, insiders sold 0 shares of Achieve Life Sciences Inc (ACHV) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Achieve Life Sciences Inc (ACHV) were sold and 25,000 shares were bought by its insiders, resulting in a net purchase of 25,000 shares.

Achieve Life Sciences Inc (ACHV)'s detailed insider trading history can be found in Insider Trading Tracker table.

Achieve Life Sciences Inc Insider Transactions

No Available Data

Thomas Braxton King Mailing Address

Above is the net worth, insider trading, and ownership report for Thomas Braxton King. You might contact Thomas Braxton King via mailing address: 91 James Avenue, Atherton Ca 94027.

Research Tools

All-In-One Screener Stock Ideas Stock List Guru List Guru Real-Time Picks Insider List Insider Trades Economic Indicators Sector & Industry Performance DCF Calculator Discussion Board

Product

Pricing Plans Excel Add-In Google Sheets Add-on Data API Stock Comparison Table Manual of Stocks Instant Alerts Mobile App 中文

Education

Financial Glossary Tutorials FAQ Schedule Free Session Buffett Indicator Shiller P/E Yield Curve Today U.S. Inflation Rate Global Market Valuation Fed Net Liquidity Buffett Assets Allocation

Company

About GuruFocus Career Contact Us Advertise Site Map Term of Use Privacy Policy Referral Program Partner Program

Survey

We'd love to learn more about your experiences on GuruFocus.com and how we can improve!

Take Survey

Disclaimers

GuruFocus.com is not operated by a broker or a dealer. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes are provided by QuoteMedia, Inc. (CSI). Company fundamental data is provided by Morningstar. Analyst estimates data is sourced from both Refinitiv and Morningstar, with priority given to Refinitiv data. Data is updated daily.